Skip to main content
Top
Published in: Radiation Oncology 1/2009

Open Access 01-12-2009 | Research

The TGF-β1 dynamics during radiation therapy and its correlation to symptomatic radiation pneumonitis in lung cancer patients

Authors: Ji-Yoon Kim, Yeon-Sil Kim, Young-Kyoon Kim, Hyun-Jin Park, Seung-Joon Kim, Jin-Hyoung Kang, Young-Pil Wang, Hong-Seok Jang, Sang-Nam Lee, Sei-Chul Yoon

Published in: Radiation Oncology | Issue 1/2009

Login to get access

Abstract

Backgroud

The underlying molecular and cellular mechanisms of radiation pneumonitis (RP) are very complex. Several biological factors need to be considered together with the well known dosimetric parameters for understanding the molecular events in developing RP in lung cancer patients. The aim of this study was to correlate the variations of the cytokine levels in lung cancer patients during radiation therapy (RT) with the occurrence of symptomatic RP.

Methods

Thirty-four lung cancer patients who received three-dimensional conformal radiation therapy were evaluated prospectively. Serial blood samples before, at the beginning, in the middle of, at the end of RT and 2 and 4 weeks after RT were analyzed for IL-1α, IL-6, IL-10, TNF-α and TGF-β1 by performing enzyme-linked immunosorbent assay. The predictive values of dosimetric factors for RP were evaluated, too.

Results

Overall, 8 patients (23.5%) had grade ≥ 2 RP. By serial measurement of cytokines level, only the TGF-β1 level showed a correlation to the symptomatic RP. None of the other cytokines, IL-1α, IL-6, IL-10 and TNF-α level was correlated with the risk of RP. The mean pretreatment TGF-β1 level did not differ between RP and non-RP groups. However, during the period of radiation treatment, the TGF-β1 level began to increase at the end of RT in the RP group and became significantly higher 4 weeks after RT (p = 0.007). Using an ANOVA model for repeated-measures, we found significant associations between the changes of TGF-β1 during the time course of the RT and the risk of developing RP (p < 0.001). Most of the dosimetric factors showed a significant association with RP.

Conclusion

Our results show that the changes of TGF-β1 could be correlated with RP and the incorporation of the biological parameters into the dosimetric data could be useful for predicting symptomatic RP.
Appendix
Available only for authorised users
Literature
1.
go back to reference Willner J, Caragiani E, Tschammler A, Flentje M: Dose, volume, and tumor control prediction in primary radiotherapy of non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2002, 52: 382-389.CrossRefPubMed Willner J, Caragiani E, Tschammler A, Flentje M: Dose, volume, and tumor control prediction in primary radiotherapy of non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2002, 52: 382-389.CrossRefPubMed
2.
go back to reference Kong FM, Ten Haken RK, Schipper MJ, Sullivan MA, Chen M, Lopez C, Kalemkerian GP, Hayman JA: High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: Long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys 2005, 63: 324-333.CrossRefPubMed Kong FM, Ten Haken RK, Schipper MJ, Sullivan MA, Chen M, Lopez C, Kalemkerian GP, Hayman JA: High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: Long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys 2005, 63: 324-333.CrossRefPubMed
4.
go back to reference Chevalier TL, Arriagada R, Quoix E, Ruffie P, Martin M, Douillar JY, Tarayre M, Lacombe-Terrier MJ, Laplanche A: Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma. Lung Cancer 1994,10(Suppl 1):S239-S244. 10.1016/0169-5002(94)91687-XCrossRefPubMed Chevalier TL, Arriagada R, Quoix E, Ruffie P, Martin M, Douillar JY, Tarayre M, Lacombe-Terrier MJ, Laplanche A: Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma. Lung Cancer 1994,10(Suppl 1):S239-S244. 10.1016/0169-5002(94)91687-XCrossRefPubMed
5.
go back to reference Mehta V: Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: Pulmonary function, prediction, and prevention. Int J Radiat Oncol Biol Phys 2005, 63: 5-24.CrossRefPubMed Mehta V: Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: Pulmonary function, prediction, and prevention. Int J Radiat Oncol Biol Phys 2005, 63: 5-24.CrossRefPubMed
6.
go back to reference Lee JS, Komaki R, Fossella FV, Dundas GS, McDonald S, Byhardt RW, Curran WJ Jr: Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06. J Clin Oncol 1996, 14: 1055-1064.PubMed Lee JS, Komaki R, Fossella FV, Dundas GS, McDonald S, Byhardt RW, Curran WJ Jr: Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06. J Clin Oncol 1996, 14: 1055-1064.PubMed
7.
go back to reference Kouroussis C, Mavroudis D, Kakolyris S, Voloudaki A, Kalbakis K, Souglakos J, Agelaki S, Malas K, Bozionelou V, Georgoulias V: High incidence of pulmonary toxicity of weekly docetaxel and gemcitabine in patients with non-small cell lung cancer: results of a dose-finding study. Lung cancer 2004, 44: 363-368. 10.1016/j.lungcan.2003.12.004CrossRefPubMed Kouroussis C, Mavroudis D, Kakolyris S, Voloudaki A, Kalbakis K, Souglakos J, Agelaki S, Malas K, Bozionelou V, Georgoulias V: High incidence of pulmonary toxicity of weekly docetaxel and gemcitabine in patients with non-small cell lung cancer: results of a dose-finding study. Lung cancer 2004, 44: 363-368. 10.1016/j.lungcan.2003.12.004CrossRefPubMed
8.
go back to reference Claude L, Perol D, Ginestet C, Falcheroc L, Arpind D, Vincente M, Martela I, Hominalf S, Cordierg JF, Carrie C: A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis. Radiother Oncol 2004, 71: 175-181. 10.1016/j.radonc.2004.02.005CrossRefPubMed Claude L, Perol D, Ginestet C, Falcheroc L, Arpind D, Vincente M, Martela I, Hominalf S, Cordierg JF, Carrie C: A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis. Radiother Oncol 2004, 71: 175-181. 10.1016/j.radonc.2004.02.005CrossRefPubMed
9.
go back to reference Wang S, Liao Z, Wei X, Liu HH, Tucker SL, Hu CS, Mohan R, Cox JD, Komaki R: Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer(NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy(3D-CRT). Int J Radiat Oncol Biol Phys 2006, 66: 1399-1407.CrossRefPubMed Wang S, Liao Z, Wei X, Liu HH, Tucker SL, Hu CS, Mohan R, Cox JD, Komaki R: Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer(NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy(3D-CRT). Int J Radiat Oncol Biol Phys 2006, 66: 1399-1407.CrossRefPubMed
10.
go back to reference Vujaskovic Z, Marks LB, Anscher MS: The physical parameters and molecular events associated with radiation-induced lung toxicity. Semin Radiat Oncol 2000, 10: 296-307. 10.1053/srao.2000.9424CrossRefPubMed Vujaskovic Z, Marks LB, Anscher MS: The physical parameters and molecular events associated with radiation-induced lung toxicity. Semin Radiat Oncol 2000, 10: 296-307. 10.1053/srao.2000.9424CrossRefPubMed
11.
go back to reference Hartsell WF, Scott CB, Dundas GS, Mohiuddin M, Meredith RF, Rubin P, Weigensberg IJ: Can serum markers be used to predict acute and late toxicity in patients with lung cancer ? analysis of RTOG 91-03. Am J Clin Oncol 2007, 30: 368-376. 10.1097/01.coc.0000260950.44761.74CrossRefPubMed Hartsell WF, Scott CB, Dundas GS, Mohiuddin M, Meredith RF, Rubin P, Weigensberg IJ: Can serum markers be used to predict acute and late toxicity in patients with lung cancer ? analysis of RTOG 91-03. Am J Clin Oncol 2007, 30: 368-376. 10.1097/01.coc.0000260950.44761.74CrossRefPubMed
12.
go back to reference Chen Y, Williams J, Ding I, Hernady E, Liu W, Smudzin T, Finkelstein JN, Rubin P, Okunieff P: Radiation pneumonitis and early circulatory cytokine markers. Semin Radiat Oncol 2002,12(Suppl 1):26-33. 10.1053/srao.2002.31360CrossRefPubMed Chen Y, Williams J, Ding I, Hernady E, Liu W, Smudzin T, Finkelstein JN, Rubin P, Okunieff P: Radiation pneumonitis and early circulatory cytokine markers. Semin Radiat Oncol 2002,12(Suppl 1):26-33. 10.1053/srao.2002.31360CrossRefPubMed
13.
go back to reference Chen Y, Rubin P, Williams J, Hernady E, Smudzin T, Okunieff P: Circulating IL-6 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys 2001, 49: 641-648.CrossRefPubMed Chen Y, Rubin P, Williams J, Hernady E, Smudzin T, Okunieff P: Circulating IL-6 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys 2001, 49: 641-648.CrossRefPubMed
14.
go back to reference Hur WJ, Yoon SM, Lee HS, Yang KM, Shin GH, Son CH, Han JY, Lee KN, Jeong MH: The measurements of plasma cytokines in radiation-induced pneumonitis in lung cancer patients. J Korean Soc Ther Oncol 2000, 18: 314-320. Hur WJ, Yoon SM, Lee HS, Yang KM, Shin GH, Son CH, Han JY, Lee KN, Jeong MH: The measurements of plasma cytokines in radiation-induced pneumonitis in lung cancer patients. J Korean Soc Ther Oncol 2000, 18: 314-320.
15.
go back to reference Hart JP, Broadwater G, Rabbani Z, Moeller BJ, Clough R, Huang D, Sempowsk GA, Dewhirst M, Pizzo SV, Vujaskovic Z, Anscher MS: Cytokine profiling for prediction of symptomatic radiation-induced lung injury. Int J Radiat Oncol Biol Phys 2005, 63: 1448-1454. 10.1016/j.ijrobp.2005.05.032CrossRefPubMed Hart JP, Broadwater G, Rabbani Z, Moeller BJ, Clough R, Huang D, Sempowsk GA, Dewhirst M, Pizzo SV, Vujaskovic Z, Anscher MS: Cytokine profiling for prediction of symptomatic radiation-induced lung injury. Int J Radiat Oncol Biol Phys 2005, 63: 1448-1454. 10.1016/j.ijrobp.2005.05.032CrossRefPubMed
16.
go back to reference Ishii Y, Kimura S: Soluble intercellular adhesion molecule-1 as an early detection marker for radiation pneumonitis. Eur Respir J 1999, 13: 733-138. 10.1034/j.1399-3003.1999.13d06.xCrossRefPubMed Ishii Y, Kimura S: Soluble intercellular adhesion molecule-1 as an early detection marker for radiation pneumonitis. Eur Respir J 1999, 13: 733-138. 10.1034/j.1399-3003.1999.13d06.xCrossRefPubMed
17.
go back to reference Barthelemy-Brichant N, Bosquee L, Cataldo D, Corhay JL, Gustin M, Seidel L, Thiry A, Ghaye B, Nizet M, Albert A, Deneufbourg JM, Bartsch P, Nusgens B: Increased IL-6 and TGF-β1 concentrations in bronchoalveolar lavage fluid associated with thoracic radiotherapy. Int J Radiat Oncol Biol Phys 2004, 58: 758-767.CrossRefPubMed Barthelemy-Brichant N, Bosquee L, Cataldo D, Corhay JL, Gustin M, Seidel L, Thiry A, Ghaye B, Nizet M, Albert A, Deneufbourg JM, Bartsch P, Nusgens B: Increased IL-6 and TGF-β1 concentrations in bronchoalveolar lavage fluid associated with thoracic radiotherapy. Int J Radiat Oncol Biol Phys 2004, 58: 758-767.CrossRefPubMed
18.
go back to reference Novakova-Jiresova A, Gameren MM, Coppes RP, Kampinga HH, Groen H: Transforming growth factor-β plasma dynamics and post-irradiation lung injury in lung cancer patients. Radiother Oncol 2004, 71: 183-189. 10.1016/j.radonc.2004.01.019CrossRefPubMed Novakova-Jiresova A, Gameren MM, Coppes RP, Kampinga HH, Groen H: Transforming growth factor-β plasma dynamics and post-irradiation lung injury in lung cancer patients. Radiother Oncol 2004, 71: 183-189. 10.1016/j.radonc.2004.01.019CrossRefPubMed
19.
go back to reference Kong FM, Washington MK, Jirtle RL, Anscher MS: Plasma transforming growth factor-β1 reflects disease status in patients with lung cancer after radiotherapy: a possible tumor marker. Lung Cancer 1996, 16: 47-59. 10.1016/S0169-5002(96)00611-3CrossRefPubMed Kong FM, Washington MK, Jirtle RL, Anscher MS: Plasma transforming growth factor-β1 reflects disease status in patients with lung cancer after radiotherapy: a possible tumor marker. Lung Cancer 1996, 16: 47-59. 10.1016/S0169-5002(96)00611-3CrossRefPubMed
20.
go back to reference Zhao L, Sheldon K, Chen M, Yin MS, Hayman JA, Kalemkerian GP, Arenberg D, Lyons SE, Curtis JL, Davis M, Cease KB, Brenner D, Anscher MS, Lawrence TS, Kong FM: The predictive role of plasma TGF-beta1 during radiation therapy for radiation-induced lung toxicity deserves further study in patients with non-small cell lung cancer. Lung Cancer 2008, 59: 232-239. 10.1016/j.lungcan.2007.08.010CrossRefPubMed Zhao L, Sheldon K, Chen M, Yin MS, Hayman JA, Kalemkerian GP, Arenberg D, Lyons SE, Curtis JL, Davis M, Cease KB, Brenner D, Anscher MS, Lawrence TS, Kong FM: The predictive role of plasma TGF-beta1 during radiation therapy for radiation-induced lung toxicity deserves further study in patients with non-small cell lung cancer. Lung Cancer 2008, 59: 232-239. 10.1016/j.lungcan.2007.08.010CrossRefPubMed
21.
go back to reference Zhao L, Wang L, Ji W, Wang X, Zhu X, Hayman JA, Kalemkerian GP, Yang W, Brenner D, Lawrence TS, Kong FM: Elevation of plasma TGF-beta1 during radiation therapy predicts radiation-induced lung toxicity in patients with non-small-cell lung cancer: a combined analysis from Beijing and Michigan. Int J Radiat Oncol Biol Phys 2009, 74: 1385-1390.CrossRefPubMed Zhao L, Wang L, Ji W, Wang X, Zhu X, Hayman JA, Kalemkerian GP, Yang W, Brenner D, Lawrence TS, Kong FM: Elevation of plasma TGF-beta1 during radiation therapy predicts radiation-induced lung toxicity in patients with non-small-cell lung cancer: a combined analysis from Beijing and Michigan. Int J Radiat Oncol Biol Phys 2009, 74: 1385-1390.CrossRefPubMed
22.
go back to reference Wakefield LM, Letterio J, Chen J, Danielpour D, Allison RS, Pai LH, Denicoff AM, Noone MH, Cowan KH, O'Shaughnessy JA: Transforming growth factor-beta1 circulates in normal human plasma and is unchanged in advanced metastatic breast cancer. Clin Cancer Res 1995, 1: 129-136.PubMed Wakefield LM, Letterio J, Chen J, Danielpour D, Allison RS, Pai LH, Denicoff AM, Noone MH, Cowan KH, O'Shaughnessy JA: Transforming growth factor-beta1 circulates in normal human plasma and is unchanged in advanced metastatic breast cancer. Clin Cancer Res 1995, 1: 129-136.PubMed
23.
go back to reference Arpin D, Perol D, Blay JY, Falchero L, Claude L, Vuillermoz-Blas S, Martel-Lafay I, Ginestet C, Alberti L, Nosov D, Etienne-Mastroianni B, Cottin V, Perol M, Guerin JC, Cordier JF, Carrie C: Early variations of circulating interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneumonitis. J Clin Oncol 2005, 23: 8748-8756. 10.1200/JCO.2005.01.7145CrossRefPubMed Arpin D, Perol D, Blay JY, Falchero L, Claude L, Vuillermoz-Blas S, Martel-Lafay I, Ginestet C, Alberti L, Nosov D, Etienne-Mastroianni B, Cottin V, Perol M, Guerin JC, Cordier JF, Carrie C: Early variations of circulating interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneumonitis. J Clin Oncol 2005, 23: 8748-8756. 10.1200/JCO.2005.01.7145CrossRefPubMed
24.
go back to reference Chen Y, Hyrien O, William J, Okunieff P, Smudzin T, Rubin P: Interlekin (IL)-1A and IL-6: Application to the predictive diagnostic testing of radiation pneumonitis. Int J Radiat Oncol Biol Phys 2005, 62: 260-266. 10.1016/j.ijrobp.2005.01.041CrossRefPubMed Chen Y, Hyrien O, William J, Okunieff P, Smudzin T, Rubin P: Interlekin (IL)-1A and IL-6: Application to the predictive diagnostic testing of radiation pneumonitis. Int J Radiat Oncol Biol Phys 2005, 62: 260-266. 10.1016/j.ijrobp.2005.01.041CrossRefPubMed
25.
go back to reference De Vita F, Orditura M, Auriemma A, Infusino S, Roscigno A, Catalano G: Serum levels of interleukin-6 as a prognostic factor in advanced non-small cell cancer. Oncology reports 1998, 5: 649-652.PubMed De Vita F, Orditura M, Auriemma A, Infusino S, Roscigno A, Catalano G: Serum levels of interleukin-6 as a prognostic factor in advanced non-small cell cancer. Oncology reports 1998, 5: 649-652.PubMed
Metadata
Title
The TGF-β1 dynamics during radiation therapy and its correlation to symptomatic radiation pneumonitis in lung cancer patients
Authors
Ji-Yoon Kim
Yeon-Sil Kim
Young-Kyoon Kim
Hyun-Jin Park
Seung-Joon Kim
Jin-Hyoung Kang
Young-Pil Wang
Hong-Seok Jang
Sang-Nam Lee
Sei-Chul Yoon
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Radiation Oncology / Issue 1/2009
Electronic ISSN: 1748-717X
DOI
https://doi.org/10.1186/1748-717X-4-59

Other articles of this Issue 1/2009

Radiation Oncology 1/2009 Go to the issue